POLONELLI, Luciano
 Distribuzione geografica
Continente #
NA - Nord America 11.711
EU - Europa 10.093
AS - Asia 6.951
SA - Sud America 962
AF - Africa 91
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 7
Totale 29.831
Nazione #
US - Stati Uniti d'America 11.310
CN - Cina 3.173
SG - Singapore 2.374
UA - Ucraina 2.095
IE - Irlanda 1.805
DE - Germania 1.621
SE - Svezia 1.216
FI - Finlandia 1.183
BR - Brasile 869
IT - Italia 861
HK - Hong Kong 859
NL - Olanda 538
CA - Canada 364
RU - Federazione Russa 239
TR - Turchia 216
GB - Regno Unito 147
AT - Austria 132
FR - Francia 101
IN - India 73
BE - Belgio 44
VN - Vietnam 37
AR - Argentina 36
IQ - Iraq 33
BD - Bangladesh 30
JP - Giappone 23
ES - Italia 21
PK - Pakistan 20
ZA - Sudafrica 20
MX - Messico 18
PL - Polonia 17
EC - Ecuador 16
EU - Europa 15
MA - Marocco 15
CZ - Repubblica Ceca 14
SA - Arabia Saudita 14
VE - Venezuela 14
AE - Emirati Arabi Uniti 13
ID - Indonesia 13
EG - Egitto 12
KE - Kenya 11
IL - Israele 10
UZ - Uzbekistan 10
CO - Colombia 9
LT - Lituania 9
CI - Costa d'Avorio 7
JO - Giordania 7
RO - Romania 7
NP - Nepal 6
AL - Albania 5
AZ - Azerbaigian 5
BG - Bulgaria 5
HU - Ungheria 5
NG - Nigeria 5
PS - Palestinian Territory 5
PY - Paraguay 5
AU - Australia 4
BY - Bielorussia 4
LK - Sri Lanka 4
LU - Lussemburgo 4
OM - Oman 4
PE - Perù 4
BB - Barbados 3
BO - Bolivia 3
CH - Svizzera 3
CL - Cile 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
HR - Croazia 3
JM - Giamaica 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
ZW - Zimbabwe 3
CM - Camerun 2
CR - Costa Rica 2
EE - Estonia 2
GE - Georgia 2
GY - Guiana 2
KG - Kirghizistan 2
LB - Libano 2
MY - Malesia 2
NI - Nicaragua 2
PT - Portogallo 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
SN - Senegal 2
TG - Togo 2
AO - Angola 1
BH - Bahrain 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
GR - Grecia 1
HN - Honduras 1
IR - Iran 1
KW - Kuwait 1
Totale 29.816
Città #
Jacksonville 2.243
Dublin 1.804
Singapore 1.422
Chandler 1.158
Beijing 876
Hong Kong 854
Dearborn 780
Ashburn 750
Nanjing 644
Boardman 583
San Mateo 570
Santa Clara 558
Princeton 504
Toronto 317
Des Moines 264
Ann Arbor 245
Bremen 243
Helsinki 216
Wilmington 216
Moscow 215
Shenyang 189
Izmir 182
Munich 180
Kunming 169
Nanchang 164
Hebei 160
Hefei 160
Parma 140
Vienna 124
New York 116
Shanghai 108
Düsseldorf 103
Grafing 101
Jinan 97
Tianjin 76
Jiaxing 74
Changsha 73
Fremont 61
Seattle 60
São Paulo 60
Guangzhou 53
Woodbridge 52
Marseille 47
Brussels 42
Turku 42
Columbus 40
Los Angeles 37
Norwalk 36
Houston 35
Milan 29
Hangzhou 28
Rio de Janeiro 27
Rome 27
Council Bluffs 26
Borås 22
Brasília 22
Zhengzhou 22
Chengdu 20
Dallas 20
The Dalles 20
Porto Alegre 19
Belo Horizonte 18
Frankfurt am Main 18
London 18
Rockville 17
Ningbo 16
Wuhan 16
Taizhou 15
San Francisco 14
Fuzhou 13
Ho Chi Minh City 13
Brooklyn 12
Chicago 12
Haikou 12
Ottawa 12
Taiyuan 12
Wenzhou 12
Nairobi 11
Nakano 11
Reggio Nell'emilia 11
Sharjah 11
Amsterdam 10
Baghdad 10
Curitiba 10
Kocaeli 10
Modena 10
Pune 10
Quito 10
Salvador 10
Washington 10
Auburn Hills 9
Hanoi 9
Johannesburg 9
Redwood City 9
Shaoxing 9
Tashkent 9
Xian 9
Boston 8
Cairo 8
Campinas 8
Totale 17.976
Nome #
A transphyletic anti-infectious control strategy based on the killer phenomenon. 223
Il problema dell’antibiogramma nelle infezioni da funghi filamentosi. 157
Antibiocorpi: Anticorpi anti-idiotipo ad attività antibiotica in vivo ed in vitro 141
Dissecting the structure-function relationship of a fungicidal peptide derived from the constant region of human immunoglobulins 140
Caratterizzazione ed isotipizzazione di anticorpi monoclonali murini anti-laminarina con potenziale attività candidacida. 138
Novel activity of a synthetic decapeptide against Toxoplasma gondii Tachyzoites 125
Anaflatoxin B1 as the Paradigm of a New Class of Vaccines Based on “Mycotoxoids” 125
L’antibiogramma per i miceti 124
Peptides of the Constant Region of Antibodies Display Fungicidal Activity 124
Micologia Clinica. Manuale di Laboratorio. 121
Antibodies as a source of anti-infective peptides: an update 121
Antifungal peptides within the antibodies 118
Fungicidal activity of peptides encoded by immunoglobulin genes 117
Antifungal properties of newly designed carbonic anhydrases inhibitors selective for microbial enzymes 115
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 111
A synthetic peptide as a novel anticryptococcal agent 110
Oral and maxillofacial fungal infections 110
Metabolic profiling of Candida albicans 109
AFM1 in Milk: Physical, Biological, and Prophylactic Methods to Mitigate Contamination 107
Analisi dell’attività fungicida di un peptide derivato dalla regione costante di immunoglobuline M umane 106
Significato diagnostico delle IgA (secretorie) adese a miceti lievitiformi nel corso delle infezioni orali di pazienti a rischio. 106
Antibody-mediated protective immunity in fungal infections 103
Antibody peptide based antifungal immunotherapy 102
Antibody constant region peptides can display immunomodulatory activity through activation of the Dectin-1 signalling pathway. 100
ANTIMICROBIAL EFFECT ON CANDIDA ALBICANS BY DIFFERENT COUPLING OF WAVELENGTHS AND COLORS IN PHOTODYNAMIC PROTOCOLS: IN VITRO AND IN VIVO STUDY 100
Anticorpi antibiotici antiidiotipo immagini interne di tossine killer. 100
Antimicrobial activity of poultry bone and meat trimmings hydrolyzates in low-sodium turkey food 99
Effect of different wavelengths and dyes on Candida albicans: In vivo study using Galleria mellonella as an experimental model 99
Anti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies 98
A Naturally Occurring Antibody Fragment Neutralizes Infectivity of Diverse Infectious Agents 98
Peptides from the inside of the antibodies are active against infectious agents and tumours 97
Vaccination of lactating dairy cows for the prevention of Aflatoxin B1 carry over in milk 96
Yeast killer toxin-like candidacidal Ab6 antibodies elicited through the manipulation of the idiotypic cascade 96
Antifungal activity of the C-terminal peptide from human serum albumin 95
Production of an engineered killer peptide in Nicotiana benthamiana by using a Potato virus X expression system 94
Significato diagnostico di IgA secretorie adese a cellule lievitiformi nelle candidosi orali 93
Antibiocorpi: anticorpi anti-idiotipo ad attività antibiotica 92
Anaerobic yeast killer system. 92
Conformation-sensitive Antibodies against Alzheimer Amyloid-beta by Immunization with a Thioredoxin-constrained B-cell Epitope Peptide 92
Antireceptor yeast killer toxin-like antibiobodies 92
Antibody Complementarity-Determining Regions (CDRs): A Bridge between Adaptive and Innate Immunity 92
Antibodies as unlimited source of anti-infective, anti-tumor and immunomodulatory peptides 92
Selective miRNA down-regulation in the inhibition of HIV-1 replication by a human serum antibody-derived peptide 92
Involvement of beta-glucans in the wide-spectrum antimicrobial activity of Williopsis saturnus var. mrakii MUCL 41968 killer toxin 90
Anticorpi immagini interne di tossine killer 90
A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities 90
Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation 90
Anti-idiotypic vaccination against group B streptococci 90
Dissection of the Structural Features of a Fungicidal Antibody-Derived Peptide 90
Clonaggio e sequenziamento dei geni codificanti per la tossina killer di Pichia anomala 89
Killer peptide: a novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs 89
Innate antimicrobial and antiviral activities of antibody peptides 89
Metabolic profile of Candida albicans 89
Natural and synthetic peptides with antifungal activity 89
Chimeric symbionts expressing a Wolbachia protein stimulate mosquito immunity and inhibit filarial parasite development 89
In vitro tests: how do they influence therapeutic choices? 88
Antibiobodies: antibiotic-like antiidiotypic antibodies. 87
Activity of an engineered synthetic killer peptide on Leishmania major and Leishmania infantum promastigotes. 85
Caratterizzazione di mannoproteine da stress di Candida albicans reattive con IgA secretorie 85
Antibiobodies: antibiotic internal image antibodies 85
AC-1001 H3 CDR peptide induces apoptosis and signs of autophagy in vitro and exhibits antimetastatic activity in a syngeneic melanoma model 85
Caratterizzazione dell'epitopo polisaccaridico reattivo con IgA secretorie della mannoproteina maggiore da stress secreta da Candida albicans. 85
Anticorpi antiidiotipici ricombinanti ad attività terapeutica fungicida. 85
Therapeutic activity of a killer peptide against experimental paracoccidioidomycosis 84
Activity of nitroimidazole derivative synthetic compounds on Trichomonas vaginalis and Candida albicans isolates 84
Attività in vitro e in vivo nei confronti di Candida albicans di peptidi sintetici progettati in silico 83
A multicenter study of the in vitro activity of voriconazole against 1,996 yeast and 192 mould clinical isolates 82
Antibodies as Crypts of Antiinfective and Antitumor Peptides 82
Therapeutic Activity of an Anti-Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection 82
Cases of imported malaria in Parma observed in the period January-September 1994 82
"Antibiobodies": yeast killer toxin-like anti-idiotypic antibodies 82
Mode of action of a killer peptide against Toxoplasma gondii 82
Biological characterization of Fusapyrone and Deoxyfusapyrone, two bioactive secondary metabolites of Fusarium semitectum 81
Reversible self-assembly: A key feature for a new class of autodelivering therapeutic peptides 81
Nuovo modello di vaccinazione idiotipica e terapia anti-idiotipica nella candidosi sistemica 81
A case of disseminated fatal infection caused by Nocardia caviae. 80
Identificazione di lieviti produttori di tossine killer in vivo 80
A killer mimotope with therapeutic activity against AIDS-related opportunistic microorganisms inhibits ex vivo HIV-1 replication 80
In vitro antifungal susceptibility to six antifungal agents of 229 Candida isolates from patients with diabetes mellitus. 80
Therapeutic potential of yeast killer toxin-like antibodies and mimotopes 79
Caratterizzazione antigenica di Microsporum canis, M. distortum, M. ferrugineum e Trichophyton soudanense. 79
Biotyping of pathogenic fungi by the killer system and with monoclonal antibodies. 79
Meccanismi di resistenza ai farmaci antifungini. 78
Vaccine for the prevention of Aflatoxin B1 carry over in the milk of lactating dairy cows 78
Any antibody fragment might exert antifungal activity 78
Human natural yeast killer toxin-like antibodies 77
Immagine interna del fenomeno killer dei lieviti 77
Detection by immunofluorescent anti-idiotypic antibodies of yeast killer toxin cell wall receptors of Candida albicans. 77
Yeast killer toxins and dimorphism. 76
Inhibition performed by a synthetic microbicidal peptide on the replication of Influenza virus. Abstract 21.009 76
Antibiotic antibodies 76
Attività in vitro di anticorpi anti-idiotipo di tossine killer di lieviti su microrganismi eucarioti e procarioti 75
Biotipizzazione di microorganismi patogeni mediante il sistema killer dei lieviti. 75
A novel microtubule de-stabilizing complementarity-determining region C36L1 peptide displays antitumor activity against melanoma in vitro and in vivo 75
In vitro and in vivo anticandidal activity of killer peptide derivatives 75
Protective antifungal yeast killer toxin-like antibodies 74
Voriconazole activity against clinical yeast isolates: a multicentre Italian study 74
A microautomated dilution method for susceptibility testing with antifungal drugs. 74
Vaccini antiidiotipici ricombinanti attivi nei confronti di infezioni da batteri capsulati. 74
Marcatori epidemiologici. 74
Totale 9.427
Categoria #
all - tutte 117.237
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 117.237


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.015 13 465 401 18 467 32 456 19 581 40 502 21
2021/20222.384 23 6 7 50 83 111 333 458 97 285 95 836
2022/20235.790 940 414 267 308 585 607 48 289 2.149 20 111 52
2023/20241.866 105 189 65 53 189 511 50 100 20 133 167 284
2024/20256.781 43 565 563 307 587 571 107 210 1.281 855 464 1.228
2025/2026642 642 0 0 0 0 0 0 0 0 0 0 0
Totale 29.993